These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 165942)

  • 81. Altered estrogen receptor system in estrogen-unresponsive human endometrial adenocarcinoma cells.
    Kassan S; Mechanick JI; Gurpide E
    J Steroid Biochem; 1989 Sep; 33(3):327-33. PubMed ID: 2779223
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Correlation between concentration of cytosol estradiol receptors and activities of RNA and protein synthesis in uterine myoma].
    Ohno T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):221-9. PubMed ID: 6199443
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of tamoxifen on ultrastructure of endometrial carcinoma.
    Amano N; Ochiai K; Tohtake T; Terashima Y; Kato J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):670-4. PubMed ID: 3585111
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Oestrogen synthesis during delayed implantation in the rat.
    Watson J; Alam M
    Contraception; 1976 Jan; 13(1):101-7. PubMed ID: 1245114
    [No Abstract]   [Full Text] [Related]  

  • 87. Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.
    Hu XF; Veroni M; De Luise M; Wakeling A; Sutherland R; Watts CK; Zalcberg JR
    Int J Cancer; 1993 Nov; 55(5):873-6. PubMed ID: 8244585
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer.
    Siiteri PK
    J Endocrinol; 1981; 89 Suppl():119P-129P. PubMed ID: 6453915
    [No Abstract]   [Full Text] [Related]  

  • 89. Proceedings: Hormonal effects of tamoxifen in women with carcinoma of the breast.
    Willis KJ; London DR; Butt WR
    J Endocrinol; 1976 Jun; 69(3):51P. PubMed ID: 950545
    [No Abstract]   [Full Text] [Related]  

  • 90. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line.
    Westley BR; Hölzel F; May FE
    J Steroid Biochem; 1989 Mar; 32(3):365-72. PubMed ID: 2468045
    [TBL] [Abstract][Full Text] [Related]  

  • 92. 4-Hydroxytamoxifen binds to estrogen receptors and inhibits the growth of human endometrial cancer cells in vitro.
    Terakawa N; Shimizu I; Ikegami H; Tanizawa O; Matsumoto K
    Cancer; 1988 Apr; 61(7):1312-5. PubMed ID: 3345486
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
    Jordan VC
    J Natl Cancer Inst; 1998 Jul; 90(13):967-71. PubMed ID: 9665143
    [No Abstract]   [Full Text] [Related]  

  • 94. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F; Rochefort H
    Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
    Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparative analyses of mechanistic differences among antiestrogens.
    Wijayaratne AL; Nagel SC; Paige LA; Christensen DJ; Norris JD; Fowlkes DM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5828-40. PubMed ID: 10579349
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Binding of [3H] monohydroxytamoxifen in human breast carcinoma cytosols.
    Jordan VC; Fischer AH; Rose DP
    Eur J Cancer (1965); 1981 Jan; 17(1):121-2. PubMed ID: 7262143
    [No Abstract]   [Full Text] [Related]  

  • 98. The determination of high-affinity oestrogen receptors in human breast tumours. Critique of a method approved by the EORTC Breast Cancer Cooperative Group.
    Braunsberg H
    Eur J Cancer (1965); 1975 Feb; 11(2):101-3. PubMed ID: 165934
    [No Abstract]   [Full Text] [Related]  

  • 99. Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies.
    Hancock GR; Gertz J; Jeselsohn R; Fanning SW
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38643482
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.
    Jordan VC
    Breast Cancer Res Treat; 2021 Nov; 190(1):19-38. PubMed ID: 34398352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.